In aggregate, our RNA-seq and ATAC-seq data indicate that ER+ breast cancer cells are poised for an enhanced response to IFNγ after ER blockade, and IFNγ stimulation leads to an enhanced downstream response in HD conditions. Here, IFNG is linked to breast cancer.